Cargando…
A Recipient and Donor Both Have COVID-19 Disease. Should We Perform a Liver Transplant?
Coronavirus 2019 (COVID-19) is a new infectious disease that continues to spread globally. There is growing concern about donor-induced transmission of Coronavirus 2 (SARS ‐CoV‐2). For liver transplantation, the COVID-19 PCR test is routine, in addition to epidemiological history and clinical and ra...
Autores principales: | Tuncer, Adem, Akbulut, Sami, Baskiran, Adil, Karakas, Ezgi Erdal, Baskiran, Deniz Yavuz, Carr, Brian, Yilmaz, Sezai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7889703/ https://www.ncbi.nlm.nih.gov/pubmed/33599922 http://dx.doi.org/10.1007/s12029-021-00590-5 |
Ejemplares similares
-
Living donor liver transplantation for Budd–Chiari syndrome: Overcoming a troublesome situation
por: Ara, Cengiz, et al.
Publicado: (2016) -
Preoperative evaluation of liver volume in living donor liver transplantation
por: Baskiran, Adil, et al.
Publicado: (2017) -
Should We Use an Orphan Graft?
por: Baskıran, A., et al.
Publicado: (2017) -
Assessment of Liver Regeneration in Patients Who Have Undergone Living Donor Hepatectomy for Living Donor Liver Transplantation
por: Satilmis, Basri, et al.
Publicado: (2023) -
Effect of Pre-Transplant Covid-19 Exposure on Post-Liver Transplant Clinical Outcomes
por: Akbulut, Sami, et al.
Publicado: (2023)